What is Healios?
Founded in 2013, Healios operates at the intersection of clinical expertise and digital innovation. The company specializes in providing scalable, family-centric interventions for individuals navigating mental illness and neurodevelopmental challenges. By integrating behavioral change techniques with a robust digital platform, Healios effectively extends the reach of traditional treatment teams. This approach not only maximizes patient outcomes but also fosters sustainable health habits within the home environment. As a leader in the digital therapeutics space, the firm is redefining accessibility, ensuring that high-quality, personalized care is available regardless of geographical constraints or traditional clinical limitations.
How much funding has Healios raised?
Healios has raised a total of $12.9M across 2 funding rounds:
Private Equity
$2.9M
Series A
$10M
Private Equity (2018): $2.9M with participation from Spice Capital and Albion Capital
Series A (2021): $10M led by Albion Capital Group and InHealth Ventures
Key Investors in Healios
Albion Capital Group
A prominent venture capital firm focused on supporting high-growth technology companies with a strong emphasis on digital health and software innovation.
InHealth Ventures
A specialized investment group dedicated to backing transformative healthcare technologies that improve patient outcomes and clinical efficiency.
Spice Capital
An investment firm known for providing strategic backing to early-stage and growth-oriented companies within the technology and digital services sectors.
What's next for Healios?
With this major enterprise-level funding, Healios is well-positioned to scale its operations and deepen its clinical impact. The strategic roadmap likely involves expanding its digital footprint, enhancing its proprietary behavioral change algorithms, and forging deeper partnerships with healthcare providers to integrate its services into standard care pathways. As the demand for remote, evidence-based mental health support continues to surge, Healios is poised to leverage this capital to solidify its market leadership, potentially exploring new therapeutic areas or expanding its demographic reach to address the global mental health crisis with greater efficacy and precision.
See full Healios company page
